LBC
ABBV icon

Leigh Baldwin & Co’s AbbVie ABBV Stock Holding History

Leigh Baldwin & Co’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$443K Buy
1,761
+14
+0.8% +$3.01K 0.24% 99
2026
Q1 		$380K Buy
1,747
+45
+3% +$9.98K 0.25% 105
2025
Q4 		$389K Sell
1,702
-20
-1% -$4.56K 0.26% 102
2025
Q3 		$399K Buy
1,722
+338
+24% +$68.8K 0.22% 106
2025
Q2 		$257K Sell
1,384
-529
-28% -$98.3K 0.17% 152
2025
Q1 		$401K Buy
1,913
+174
+10% +$33.8K 0.32% 85
2024
Q4 		$309K Buy
+1,739
New +$320K 0.26% 111

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Leigh Baldwin & Co's ABBV Position: Q2 2026 in Review

Leigh Baldwin & Co increased its AbbVie (ABBV) stake by 0.8% in Q2 2026, buying an estimated $3.01K and bringing the position to 1,761 shares worth $443K. The position accounts for 0.24% of the portfolio, ranked #99.

Leigh Baldwin & Co first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Leigh Baldwin & Co held 1,761 shares of AbbVie worth $443K as of Q2 2026.
  • Leigh Baldwin & Co bought 14 AbbVie shares in Q2 2026, an estimated $3.01K.
  • AbbVie made up 0.24% of Leigh Baldwin & Co's portfolio in Q2 2026, its #99 holding.
  • Leigh Baldwin & Co first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Leigh Baldwin & Co's 13F filing for Q2 2026, filed 13 Aug 2026.